Healthcare -
Biotechnology - NASDAQ - US
$ 3.76
-0.529 %
$ 336 M
Market Cap
-8.55
P/E
TRVI - OPERATING INCOME
Operating Income TRVI - Trevi Therapeutics, Inc.
-33.9 M
LAST VALUE
-2.20%
2 YEAR CAGR
-13.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR